Carac is part of the Nucleoside Metabolic Inhibitors class and treats Actinic Keratosis and Skin Cancer. Nucleoside metabolic inhibitors are used to treat colon cancer, breast cancer, leukemia, meningitis, actinic keratosis, skin cancer, pancreatic cancer, ovarian cancer, and lung cancer. They work by slowing down the growth of cancer cells which then kills the cell. Carac is only available as a brand name drug. Compare with other Nucleoside Metabolic Inhibitors. [Learn more]
Copyright ©2013 GoodRx, Inc.
This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on GoodRx.com are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.